“…Most TNF inhibitors are ineffective for AA, while dupilumab was found to be modestly effective in a Phase IIa trial ( 46 ). Although AA is associated with atopic dermatitis and psoriasis, treatment for the latter does not always improve AA ( 47 ), and may sometimes worsen hair loss ( 48 ).…”